TransMedics Corp (TMDX): Market Cap to Revenue

Symbol and logo of brand TransMedics Group Inc (TMDX)

The current P/S valuation demonstrates the high market value of TransMedics Group (TMDX), where the 4.40 metric confirms the current level. TransMedics Group (TMDX) possesses exceptional pricing power driven by critical demand. OCS technology has achieved a breakthrough by maintaining organs in an active state. A streamlined logistics network with aviation contractors and an independent monitoring system further enhance business efficiency.

TMDX TransMedics Group Inc P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for TransMedics Corp (TMDX)

- share price and consensus valuation forecast:
Price Performance Chart TransMedics Group, Inc.|TMDX - Price Target Chart
- stock exchange capitalization data:
Market Valuation TransMedics Corp|TMDX - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share TransMedics|TMDX - Book Capitalization|Capitalization to Book Value Ratio transmedics.com|TMDX - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient TransMedics Group|TMDX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio TransMedics Organ Care System|TMDX - Company Aggregate Debts|Debts to Book Capitalization TransMedics Corp|TMDX - Company Long-Term Debt|Company Short-Term Debt TransMedics|Intermediate Coverage Ratio transmedics.com
- earnings and multiples data:
TMDX - Net Profit|Expected Net Profit TransMedics Group|TMDX - Price to Earnings Ratio|Forward Price to Earnings Multiple TransMedics|TMDX - Price/Earnings to Growth Multiple|EV/EBITDA Multiple TransMedics Corp|TMDX - Operating profit EBITDA|Net earnings per share for the last four quarters TransMedics|TMDX - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months transmedics.com|TMDX - Earnings per share growth in current year|Expected earnings per share growth for next year TransMedics Group
- issuer revenue and sales details:
TMDX - Revenue and Sales Volume|Company Expected Sales Volume TransMedics Corp|TMDX - Price-to-Revenue Ratio|Market Cap to Projected Revenue TransMedics Corp
General company analysis:TMDX transmedics.com
Core merchandise of TransMedics Group

The monopolization of the transplant market through the integration of organ life-support systems and proprietary aviation logistics makes TransMedics Group (TMDX) revenue the fundamental metric for business scaling. By analyzing the P/S multiple, investors assess the ratio of market capitalization to actual sales to determine whether market expectations regarding the company's ability to pass inflationary costs onto clinics are overstated, as reflected in the price action of this chart.

Competitors of TransMedics Group

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|Alphatec Holdings (ATEC) - Price-to-Revenue Coefficient|P/S Multiple AORT|Market Cap to Revenue Enovis Inc. ENOV|P/S Multiple IART (Integra LifeSciences)|P/S Multiple establishmentlabs.com ESTA|BBNX - Price-to-Revenue Ratio|IRMD: Price-to-Revenue Ratio|EMBC (Embecta Inc.) - Market Cap to Revenue|Tandem Corp - Market Capitalization-to-Revenue Ratio|AXGN (AxoGen, Inc.) - P/S Multiple|Price to Sales si-bone.com SIBN|Price-to-Revenue Ratio Orthofix (OFIX)|Bioventus Inc (BVS) - Price-to-Revenue Multiple|OrthoPediatrics - Market Cap to Revenue|P/S Multiple Treace Corp TMCI|Strata Critical Medical Inc - P/S Multiple|Price-to-Revenue Coefficient carlsmed.com CARL|RxSight (RXST) - Price-to-Revenue Ratio|Price-to-Sales Ratio CLPT (ClearPoint Neuro)|Price-to-Revenue Ratio Stereotaxis Corp|Market Cap to Revenue Neuronetics, Inc (STIM)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio Anika Therapeutics, Inc. ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical, Inc. - Market Cap to Sales Volume|XTNT (xtantmedical.com) - Market Cap to Revenue|NMTC: Market Cap to Sales Volume|Price-to-Revenue Ratio Modular Medical Inc|MYO: Market Capitalization-to-Revenue Ratio|P/S Multiple COCH|P/S Multiple Vivos Therapeutics Inc (VVOS)|Price-to-Revenue Ratio enVVeno Medical NVNO|SINT: Market Cap to Revenue Ratio|TNON - Price-to-Revenue Ratio|Price-to-Revenue Coefficient ReWalk Robotics LFWD|autonomix.com (AMIX) - Price-to-Revenue Ratio|Market Cap to Revenue INVO Fertility Corp|BBLG (Bone Biologics) - P/S Multiple|Price to Sales axonics.com AXNX|P/S Multiple BIOL|dynatronics.com - Market Cap to Revenue Ratio|P/S Multiple FNA (Paragon 28)|Price-to-Revenue Coefficient INVO Bioscience Inc. (INVO)